I-New laboratory confirmed diagnosis of SARS-CoV-2 via reverse transcriptase polymerase chain reaction as per the World Health Organization protocol, by nucleic acid based isothermal amplification, or by antigen testing OR II- Clinical suspicion of COVID-19 disease and acute onset (less than 10 days) and of AT LEAST ONE of the following conditions:• Loss of smell or taste• Cough or shortness of breath / dyspnea• Fever (body temperature > 38.5°)• PLUS Findings on chest-X ray or computer tomography suggestive of COVID-19 OR III- Clinical suspicion of COVID-19 disease and acute onset (less than 10 days) of AT LEAST TWO of the following conditions: • Chills or rigor • Conjunctivitis • Sore throat • Gastrointestinal symptoms • Headaches • Fatigue or malaise • Aches or pain PLUS Findings on chest-X ray or computer tomography suggestive of COVID-19 18 years and older Informed consent from the patient (or legally authorized substitute decision maker).

I-New laboratory confirmed diagnosis of SARS-CoV-2 via reverse transcriptase polymerase chain reaction as per the World Health Organization protocol, by nucleic acid based isothermal amplification, or by antigen testing OR II- Clinical suspicion of COVID-19 disease and acute onset (less than 10 days) and of AT LEAST ONE of the following conditions:• Loss of smell or taste• Cough or shortness of breath / dyspnea• Fever (body temperature > 38.5°)• PLUS Findings on chest-X ray or computer tomography suggestive of COVID-19 OR III- Clinical suspicion of COVID-19 disease and acute onset (less than 10 days) of AT LEAST TWO of the following conditions: • Chills or rigor • Conjunctivitis • Sore throat • Gastrointestinal symptoms • Headaches • Fatigue or malaise • Aches or pain PLUS Findings on chest-X ray or computer tomography suggestive of COVID-19 18 years and older Informed consent from the patient (or legally authorized substitute decision maker).